Patents by Inventor Scott Morham

Scott Morham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface
    Patent number: 7943146
    Abstract: The present invention provides methods for preventing and treating HIV infection and AIDS by introducing cells displaying HIV late-domain phenotype into a patient, or by administering to a patient nucleic acids, polypeptides or small organic compounds to cause the formation of cells displaying HIV late-domain phenotype in the body of the patient.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: May 17, 2011
    Assignee: Myrexis, Inc.
    Inventors: Adrian Hobden, Kenton Zavitz, Scott Morham
  • IMMUNIZING COMPOSITIONS COMPRISING HIV-1 PROVIRAL CONSTRUCTS WITH AN INACTIVE P6 GAG TSG101 UEV BINDING DOMAIN CAPABLE OF PRODUCING BUDDING-DEFECTIVE VIRAL PARTICLES THAT REMAIN TETHERED TO THE CELL SURFACE.
    Publication number: 20110076248
    Abstract: The present invention provides methods for preventing and treating HIV infection and AIDS by introducing cells displaying HIV late-domain phenotype into a patient, or by administering to a patient nucleic acids, polypeptides or small organic compounds to cause the formation of cells displaying HIV late-domain phenotype in the body of the patient.
    Type: Application
    Filed: December 20, 2002
    Publication date: March 31, 2011
    Applicant: Myriad Genetics, Incorporated
    Inventors: Adrian Hobden, Kenton Zavitz, Scott Morham
  • COMPOSITION AND METHOD FOR TREATING VIRAL INFECTION
    Publication number: 20100256040
    Abstract: Methods for inhibiting virus propagation and treating virus infection are provided which include administering to cells infected with viruses a compound capable of inhibiting viral budding from the cells.
    Type: Application
    Filed: January 19, 2007
    Publication date: October 7, 2010
    Applicant: Myriad Genetics, Incorporated
    Inventors: Scott Morham, Kenton Zavitz, Adrian Hobden
  • METHOD AND COMPOSITION FOR REDUCING THE EXPRESSION OF ROCK-II
    Publication number: 20090062229
    Abstract: Methods and compositions for reducing the expression of Rho-associated, coiled-coil containing protein kinase 2 (ROCK-II) are provided.
    Type: Application
    Filed: May 6, 2008
    Publication date: March 5, 2009
    Applicant: Myriad Genetics, Incorporated
    Inventors: Scott Morham, Gongping He
  • TSG101-GAG INTERACTION AND USE THEREOF
    Publication number: 20090035853
    Abstract: Isolated protein complexes are provided comprising Tsg101 and HIV GAG or GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAG or GAGp6 interaction within the protein complexes.
    Type: Application
    Filed: February 22, 2008
    Publication date: February 5, 2009
    Applicant: Myriad Genetics, Incorporated
    Inventors: Kenton Zavitz, Scott Morham, Daniel Albert Wettstein
  • Method and composition for reducing expression of ROCK-II
    Patent number: 7371850
    Abstract: Methods and pharmaceutical compositions for treating, and delaying the onset of, viral infection, are provided.
    Type: Grant
    Filed: August 20, 2004
    Date of Patent: May 13, 2008
    Assignee: Myriad Genetics, Inc.
    Inventors: Scott Morham, Gongping He
  • TSG101-GAG interaction and use thereof
    Patent number: 7335468
    Abstract: Isolated protein complexes are provided comprising Tsg101 and HIV GAG or GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAG or GAGp6 interaction within the protein complexes.
    Type: Grant
    Filed: September 15, 2003
    Date of Patent: February 26, 2008
    Assignee: Myriad Genetics, Inc.
    Inventors: Kenton Zavitz, Scott Morham, Daniel Albert Wettstein
  • COMPOSITION AND METHOD FOR TREATING HIV INFECTION
    Publication number: 20070213271
    Abstract: Methods for inhibiting HIV propagation and treating HIV infection are provided which include administering to cells infected with HIV a compound capable of inhibiting viral budding from the infected host cells. The methods are especially useful in treating HIV infection and in treating and preventing AIDS.
    Type: Application
    Filed: January 24, 2007
    Publication date: September 13, 2007
    Applicant: Myriad Genetics, Incorporated
    Inventors: Kenton Zavitz, Daniel Wettstein, Scott Morham, Adrian Hobden
  • Tsg101-GAGp6 interaction and use thereof
    Patent number: 7202329
    Abstract: Isolated protein complexes are provided comprising Tsg101 and HIV GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAGp6 interaction within the protein complexes.
    Type: Grant
    Filed: October 4, 2001
    Date of Patent: April 10, 2007
    Assignee: Myriad Genetics, Inc.
    Inventors: Daniel Albert Wettstein, Scott Morham, Kenton Zavitz
  • Therapeutic compositions and methods for treating viral infection
    Patent number: 6960431
    Abstract: Methods for inhibiting viral propagation and treating viral infection are provided which include administering to cells infected with viruses a therapeutic peptide or a derivative thereof.
    Type: Grant
    Filed: August 22, 2002
    Date of Patent: November 1, 2005
    Assignee: Myriad Genetics, Inc.
    Inventors: Scott Morham, Kenton Zavitz, Adrian Hobden
  • TSG101-GAG interaction and use thereof
    Publication number: 20040109861
    Abstract: Isolated protein complexes are provided comprising Tsg101 and HIV GAG or GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAG or GAGp6 interaction within the protein complexes.
    Type: Application
    Filed: September 15, 2003
    Publication date: June 10, 2004
    Applicant: Myriad Genetics, Incorporated
    Inventors: Kenton Zavitz, Scott Morham, Daniel Albert Wettstein
  • Composition and method for treating viral infection
    Publication number: 20030171318
    Abstract: Methods for inhibiting virus propagation and treating virus infection are provided which include administering to cells infected with viruses a compound capable of inhibiting viral budding from the cells.
    Type: Application
    Filed: August 20, 2002
    Publication date: September 11, 2003
    Applicant: Myriad Genetics, Incorporated
    Inventors: Scott Morham, Kenton Zavitz, Adrian Hobden
  • Therapeutic compositions and methods for treating viral infection
    Publication number: 20030166504
    Abstract: Methods for inhibiting viral propagation and treating viral infection are provided which include administering to cells infected with viruses a therapeutic peptide or a derivative thereof.
    Type: Application
    Filed: August 22, 2002
    Publication date: September 4, 2003
    Applicant: Myriad Genetics, Incorporated
    Inventors: Scott Morham, Kenton Zavitz, Adrian Hobden
  • Composition and method for treating HIV infection
    Publication number: 20030138444
    Abstract: Methods for inhibiting HIV propagation and treating HIV infection are provided which include administering to cells infected with HIV a compound capable of inhibiting viral budding from the infected host cells. The methods are especially useful in treating HIV infection and in treating and preventing AIDS.
    Type: Application
    Filed: August 19, 2002
    Publication date: July 24, 2003
    Applicant: Myriad Genetics, Incorporated
    Inventors: Kenton Zavitz, Daniel Albert Wettstein, Scott Morham, Adrian Hobden
  • Compositions and therapeutic methods for viral infection
    Publication number: 20030105277
    Abstract: Methods for inhibiting viral propagation and treating viral infection are provided which include administering to cells infected with viruses a compound capable of inhibiting viral budding from the infected host cells.
    Type: Application
    Filed: August 21, 2002
    Publication date: June 5, 2003
    Applicant: Myriad Genetics, Incorporated
    Inventors: Scott Morham, Kenton Zavitz, Adrian Hobden
  • Tsg101-GAGp6 interaction and use thereof
    Publication number: 20020173622
    Abstract: Isolated protein complexes are provided comprising Tsg101 and HIV GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAGp6 interaction within the protein complexes.
    Type: Application
    Filed: October 4, 2001
    Publication date: November 21, 2002
    Inventors: Daniel Albert Wettstein, Scott Morham, Kenton Zavitz